The impaired molecular machinery we observed—including reduced expression of receptors (Scarb1) and transporters (Abca1, Abcg1)—strongly suggests a functional deficit in the lymphatic RCT pathway in advanced atherosclerosis. The gene discussed is ABCG1; the disease is atherosclerosis.